256 related articles for article (PubMed ID: 9889429)
1. Long-term efficacy and adverse event of nifedipine sustained-release tablets for cyclosporin A-induced hypertension in patients with psoriasis.
Nakayama J; Koga T; Furue M
Eur J Dermatol; 1998 Dec; 8(8):563-8. PubMed ID: 9889429
[TBL] [Abstract][Full Text] [Related]
2. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
Saito I; Saruta T;
Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
[TBL] [Abstract][Full Text] [Related]
3. [Drug-induced gingival hyperplasia].
Nohl F; Ferrari P
Ther Umsch; 1998 Sep; 55(9):573-5. PubMed ID: 9789475
[TBL] [Abstract][Full Text] [Related]
4. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the effects of two modified release preparations of nifedipine-nifedipine retard 10 mg twice daily and nifedipine GITS 20 mg once daily--in the treatment of mild to moderate hypertension.
Kirby BJ; Kitchin NR
Int J Clin Pract; 1999; 53(5):339-43. PubMed ID: 10695096
[TBL] [Abstract][Full Text] [Related]
6. Gingival hyperplasia: interaction between cyclosporin A and nifedipine? A case report.
Jackson C; Babich S
N Y State Dent J; 1997 Jan; 63(1):46-8. PubMed ID: 9046179
[TBL] [Abstract][Full Text] [Related]
7. Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine.
Westbrook P; Bednarczyk EM; Carlson M; Sheehan H; Bissada NF
J Periodontol; 1997 Jul; 68(7):645-50. PubMed ID: 9249636
[TBL] [Abstract][Full Text] [Related]
8. [Slow release nifedipine in treatment of hypertension. 24-hour effect on blood pressure and heart rate--treatment follow-up of 391 patients].
Bühler G; Wadepuhl M; Nandi K; Rosenthal J
Fortschr Med; 1997 Aug; 115(24):37-8. PubMed ID: 9410819
[No Abstract] [Full Text] [Related]
9. Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days--a randomized crossover trial between benidipine and nifedipine CR.
Kojima M; Taniguchi M; Sato K; Ueda R; Dohi Y
Nephron Clin Pract; 2004; 97(2):c49-53. PubMed ID: 15218330
[TBL] [Abstract][Full Text] [Related]
10. Modifying effects of amlodipine on cyclosporin A-induced changes in renal function in patients with psoriasis.
Raman GV; Campbell SK; Farrer A; Albano JD; Cook J
J Hypertens Suppl; 1998 Sep; 16(4):S39-41. PubMed ID: 9817191
[TBL] [Abstract][Full Text] [Related]
11. [Gingival hyperplasia during treatment with nifedipine].
Bokor-Bratić M; Vucković N; Selaković S
Med Pregl; 1998; 51(9-10):445-8. PubMed ID: 9863337
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of antihypertensive drugs in pregnancy].
Tsaava F; Shonia R
Georgian Med News; 2005 Sep; (126):23-6. PubMed ID: 16234587
[TBL] [Abstract][Full Text] [Related]
13. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
[TBL] [Abstract][Full Text] [Related]
14. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR
Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
[TBL] [Abstract][Full Text] [Related]
16. Modulation of abnormalities in renal haemodynamics and vasoactive mediators by nifedipine in patients with psoriasis on low-dose cyclosporin.
Edwards BD; Chalmers RJ; O'Driscoll J; Lawson RS; Testa HJ; Ballardie FW
Nephrol Dial Transplant; 1993; 8(10):1071-8. PubMed ID: 8272218
[TBL] [Abstract][Full Text] [Related]
17. Treatment of arterial hypertension with nifedipine in patients with chronic renal insufficiency.
Ambroso GC; Como G; Scalamogna A; Citterio A; Casati S; Ponticelli C
Clin Nephrol; 1985 Jan; 23(1):41-5. PubMed ID: 3978881
[TBL] [Abstract][Full Text] [Related]
18. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Am J Hypertens; 2008 Aug; 21(8):948-54. PubMed ID: 18600215
[TBL] [Abstract][Full Text] [Related]
19. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
[TBL] [Abstract][Full Text] [Related]
20. Short- and long-term efficacy of nifedipine in hypertensive patients with impaired renal function, with special reference to influencing factors.
Matsukawa S; Suzuki H; Itaya Y; Nakajima S; Saruta T
J Clin Hypertens; 1987 Dec; 3(4):452-62. PubMed ID: 3134514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
